Re "think you can safely say 'when' not 'if'. "
Absolutely agree. I've held since 2017, disastrous for those initial 2014 holders at 40c
but I have held through the highs and lows and continued to build, such slow progress, normally I would have sold out in 2020 with the SP slump, but I have never lost faith for the PCK long term, with the patent protection and our competitive advantages.
- Forums
- ASX - By Stock
- PCK
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-33
Featured News
Add PCK (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.8¢ |
Change
-0.003(9.68%) |
Mkt cap ! $45.84M |
Open | High | Low | Value | Volume |
2.8¢ | 2.9¢ | 2.8¢ | $64.49K | 2.298M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38188 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 65000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 38188 | 0.028 |
4 | 1287037 | 0.027 |
4 | 1040000 | 0.026 |
4 | 1159601 | 0.025 |
1 | 41252 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 65000 | 1 |
0.031 | 18000 | 1 |
0.032 | 89187 | 1 |
0.033 | 100000 | 1 |
0.034 | 108791 | 1 |
Last trade - 15.14pm 12/11/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online